Cargando…
Chemerin as a Potential Marker of Resolution of Inflammation in COVID-19 Infection
Chemerin is one of the specialized pro-resolving mediators that participate in the early phase of inflammation and contribute to the initiation of the pro-resolving response. There is a paucity of data regarding the time course of chemerin during acute infections. We aimed to evaluate the sequence o...
Autores principales: | Sulicka-Grodzicka, Joanna, Surdacki, Andrzej, Surmiak, Marcin, Sanak, Marek, Wizner, Barbara, Sydor, Wojciech, Bociąga-Jasik, Monika, Strach, Magdalena, Korkosz, Mariusz, Skladany, Lubomir, Grgurevic, Ivica, Podrug, Kristian, Kukla, Michał |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599036/ https://www.ncbi.nlm.nih.gov/pubmed/36289725 http://dx.doi.org/10.3390/biomedicines10102462 |
Ejemplares similares
-
Anti-inflammatory adipokines: chemerin, vaspin, omentin concentrations and SARS-CoV-2 outcomes
por: Kukla, Michał, et al.
Publicado: (2021) -
Artificial intelligence guided HRCT assessment predicts the severity of COVID-19 pneumonia based on clinical parameters
por: Chrzan, Robert, et al.
Publicado: (2023) -
Differential Associations of Inflammatory and Endothelial Biomarkers with Disease Activity in Rheumatoid Arthritis of Short Duration
por: Klimek, Ewa, et al.
Publicado: (2014) -
Blood Monocyte Subsets and Selected Cardiovascular Risk Markers in Rheumatoid Arthritis of Short Duration in relation to Disease Activity
por: Klimek, Ewa, et al.
Publicado: (2014) -
Effectiveness and Safety of SARS-CoV-2 Vaccination in HIV-Infected Patients—Real-World Study
por: Bociąga-Jasik, Monika, et al.
Publicado: (2023)